BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1173 related articles for article (PubMed ID: 16466897)

  • 1. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
    Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
    Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
    Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
    J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
    Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ
    Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of multidrug-resistant Salmonella enterica serovar Typhi associated with a class 1 integron carrying the dfrA7 gene cassette in Nepal.
    Tamang MD; Oh JY; Seol SY; Kang HY; Lee JC; Lee YC; Cho DT; Kim J
    Int J Antimicrob Agents; 2007 Oct; 30(4):330-5. PubMed ID: 17629465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
    Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
    Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.
    Renuka K; Kapil A; Kabra SK; Wig N; Das BK; Prasad VV; Chaudhry R; Seth P
    Microb Drug Resist; 2004; 10(2):146-53. PubMed ID: 15256030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
    Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
    Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.
    Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN
    Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives.
    Pokharel BM; Koirala J; Dahal RK; Mishra SK; Khadga PK; Tuladhar NR
    Int J Infect Dis; 2006 Nov; 10(6):434-8. PubMed ID: 16978898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
    BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia.
    Yanagi D; de Vries GC; Rahardjo D; Alimsardjono L; Wasito EB; De I; Kinoshita S; Hayashi Y; Hotta H; Osawa R; Kawabata M; Shirakawa T
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):422-6. PubMed ID: 19631095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening method for Salmonella enterica serovar Typhi and serovar Paratyphi A with reduced susceptibility to fluoroquinolones by PCR-restriction fragment length polymorphism.
    Hirose K; Tamura K; Watanabe H
    Microbiol Immunol; 2003; 47(2):161-5. PubMed ID: 12680720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing trends in antimicrobial resistance of Salmonella enterica serovar typhi and salmonella enterica serovar paratyphi A in Chennai.
    Krishnan P; Stalin M; Balasubramanian S
    Indian J Pathol Microbiol; 2009; 52(4):505-8. PubMed ID: 19805957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a real-time PCR assay for detection of gyrA mutations associated with reduced susceptibility to ciprofloxacin in Salmonella enterica serovar typhi and paratyphi A.
    Morita M; Ito K; Hirose K; Takahashi H; Shimuta K; Terajima J; Ohnishi M; Harada M; Matsuzaki M; Watanabe H; Izumiya H
    Microbiol Immunol; 2006; 50(9):707-11. PubMed ID: 16985292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal.
    Maskey AP; Day JN; Phung QT; Thwaites GE; Campbell JI; Zimmerman M; Farrar JJ; Basnyat B
    Clin Infect Dis; 2006 May; 42(9):1247-53. PubMed ID: 16586383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.
    Sekar U; Srikanth P; Kindo AJ; Babu VP; Ramasubramanian V
    J Commun Dis; 2003 Sep; 35(3):162-9. PubMed ID: 15796408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Salmonella Paratyphi A enteric fever and changing trends in antimicrobial resistance pattern of salmonella in Shimla.
    Verma S; Thakur S; Kanga A; Singh G; Gupta P
    Indian J Med Microbiol; 2010; 28(1):51-3. PubMed ID: 20061765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region?
    Walther-Rasmussen J; Høiby N
    Epidemiol Infect; 2011 Aug; 139(8):1281-3; author reply 1283. PubMed ID: 21050501
    [No Abstract]   [Full Text] [Related]  

  • 20. A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A.
    Song Y; Roumagnac P; Weill FX; Wain J; Dolecek C; Mazzoni CJ; Holt KE; Achtman M
    J Antimicrob Chemother; 2010 Aug; 65(8):1631-41. PubMed ID: 20511368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.